ArticleAntibodies (Basel, Switzerland)2026

Immune-Related Adverse Events of Cemiplimab Therapy in Advanced Cervical Cancer-Data from the Polish-Czech Cervical Cancer Immunotherapy Group (PCCIG-01) with a Review of the Literature.

Radosław Łupkowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.